AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹259 Cr | ₹131 Cr | ₹85 Cr | ₹73 Cr | - |
What is the latest Total Non-Current Liabilities ratio of AARTI PHARMALABS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹259 Cr |
| Mar2024 | ₹131 Cr |
| Mar2023 | ₹85 Cr |
| Mar2022 | ₹73 Cr |
| Mar2021 | - |
How is Total Non-Current Liabilities of AARTI PHARMALABS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹259 Cr | 98.54 | |
| Mar2024 | ₹131 Cr | 53.89 | |
| Mar2023 | ₹85 Cr | 16.71 | |
| Mar2022 | ₹73 Cr | 0 | |
| Mar2021 | - | - | |
Compare Total Non-Current Liabilities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹6,888.8 Cr | 0.2% | 6.3% | 14.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹392,147.0 Cr | -5.2% | -7.6% | -8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,208.0 Cr | -5.6% | -7.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,190.0 Cr | -0.6% | 4.8% | 25% | Stock Analytics | |
| CIPLA | ₹110,790.0 Cr | -4.5% | -9.7% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,587.0 Cr | -2.6% | -9.7% | -10.5% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 0.2% |
6.3% |
14.1% |
| SENSEX | -1.3% |
-3.1% |
6.8% |
You may also like the below Video Courses